Parkwalk’s focused investment strategy, combined with its highly experienced and deep network of partners, specialist co-investors, industry experts and advisors, allows the team to make relatively rapid investment decisions, and deploy capital efficiently.

Parkwalk’s focused asset class has enabled us to develop strong and trusted relationships over the past 10 years, building a reputation as good people to do business with, and bringing with it the highest quality deal-flow.

We are the most co-invested fund in this asset class and we invest c.£50m per year into the sector.

  • Parkwalk actively seeks to co-invest with other specialist funds

  • £10m

    We have the ability to invest from £250k to £10m per round

  • Invest from early-stage through to Series C round and beyond

  • Look to follow our money and invest over multiple rounds

Co-investors

Key Parkwalk investment philosophy

  • We are willing to take early stage risk but invest across the spectrum from seed to later stage opportunities
  • We seek to invest in flat capital structures with all stakeholders (investors, founders, institutions etc) aligned in the same share class
  • We feel that by investing we are showing the founders and management respect for their business plan and vision and we expect this to be reciprocated
  • We feel these investments are a team effort between all the stakeholders and that moving forward they should all be treated fairly
  • We look to follow our money and will invest over multiple rounds
  • We have the ability to invest from £250k to £10m in any one round depending on the stage of the business
We are highly experienced with a deep network of partners, specialist co-investors, industry experts and advisors
Our focused investment strategy on a distinct asset class allows us to make insightful and rapid investment decisions
We look to align interests of all stakeholders via investing in flat capital structures, and treat all stakeholders fairly

Empowering Innovation

Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

MoA Technology

MOA is a plant genetics company using its proprietary technology to generate potential candidates for use as herbicides. The herbicide market mirrors the antibiotic market, in that there have been few new molecules developed in recent years and resistance is developing to those products on the market.

Industrial Phycology (I-Phyc)

Industrial Phycology (I-Phyc), a member of Bristol’s SETSquared technology incubator, which has developed a patented process that allows microalgae to be used consistently year-round for sustainable, chemical free treatment of process and wastewaters and the recovery and reuse of valuable materials they contain. I-Phyc has developed an advanced, modular, weather independent and containerised pro

Oxford Quantum Circuits

OQC’s mission is to put quantum in the hands of humanity, to solve some of the world’s most challenging problems. They have built the most advanced and only commercially available quantum computer in the UK and achieved performance parameters as good as or better than key competitors at a fraction of the cost.

View Portfolio